Visior Technologies Ltd.

Visior is a clinical stage medical device startup, developing Eye & Brain stimulation solutions for treating common Eye Diseases and Brain Diseases. The proprietary technology platform uses streaming commercially available audio-visual content as a vehicle for targeted stimulation, while the user is enjoying any content of their choice. Efficacy and safety was established in treating Amblyopia (TASMC, Israel, 2014), modulating ocular blood flow in Glaucoma patients (Indiana University, USA, 2016). We are currently engaged in evaluating feasibility of modulating Cerebral Blood Flow and Brain Perfusion, with promising early data, applicable to CNS and neurodegenerative related conditions.